氟桂利嗪联合头痛宁胶囊对偏头痛患者的疗效及对患者血清 MMP -9、TNF -α及 LPA 的影响

氟桂利嗪联合头痛宁胶囊对偏头痛患者的疗效及对患者血清MMP -9、TNF -α及 LPA 的影响
高萍;孟亚楠;苏立凯
【期刊名称】《临床和实验医学杂志》
【年(卷),期】2017(016)004
【摘要】Objective To investigate the curative effect of Flunarizine combined with TouTongNing Capsule in the treatment of patients with migraine,and effect on serum matrix metalloproteinase - 9(MMP - 9),tumor necrosis factor alpha(TNF - α)and lysophosphatidic acid (LPA). Methods From January 2015 to January 2016,120 cases with the diagnosis of migraine were treated in our hospital. The SAS software was used to divide randomly these cases into Toutongning group(flunarizine hydrochloride + Toutongning treatment)and conventional group(flu-narizine hydrochloride). 60 cases were in each group. Each patient was treated for 4 weeks for a course. The frequency of headache attack,the duration of headache attack and the degree of headache attack were observed. The clinical efficacy and side effects of the two groups were evalua-ted. Serum levels of MMP - 9,TNF - α and LPA were measured before and after treatment in both groups. Results After treatment,the head-ache frequency,headache duration,headache severity scores in patients of Toutongning group were lower than the normal group,the difference was statistically significant( P < 0. 05). The serum MMP - 9,TNF - α and LPA
levels of patients of Toutongning group were lower than the normal group,the difference was statistically significant( P < 0. 05). After treatment,the total efficiency in TouTongNing group was 95. 00%(57 /
60) ,which was higher than the conventional group 81. 67%(49 / 60),the difference was statistically significant( P < 0. 05). Conclusion Fluna-rizine combined with TouTongNing Capsule in the treatment of migraine patients had definite curative effect. This method can further reduce the level of serum MMP - 9,TNF - α and LPA,improve the clinical effect.%目的：探讨氟桂利嗪联合头痛宁胶囊治疗偏头痛患者的疗效及对患者血清基质金属蛋白酶-9（MMP -9）、肿瘤坏死因子-α（TNF -α）及溶血磷脂酸（LPA）水平的影响。

方法选取2015年1月至2016年1月治疗的120例偏头痛患者，随机将其分为
头痛宁组（盐酸氟桂利嗪+头痛宁治疗）、常规组（盐酸氟桂利嗪治疗）各60例，4周为一个疗程。

观察两组头痛发作频次、头痛发作持续时间、头痛发作程度评分；评价两组患者临床疗效和不良反应；检测并比较两组患者治疗前、治疗后的血清MMP -9、TNF -α及 LPA 水平。

结果治疗后，头痛宁组患者的头痛发作频次、头痛发作持续时间、头痛发作程度评分均低于常规组，差异具有统计学意义（ P ＜0.05），头痛宁组患者的血清 MMP -9、TNF -α及 LPA 水平均低于常规组，差
异具有统计学意义（ P ＜0.05）；治疗后，头痛宁组患者的总有效率95.00%（57/60）高于常规组的81.67%（49/60），差异具有统计学意义（P ＜0.05）。

结论氟桂利嗪联合头痛宁胶囊治疗偏头痛患者的疗效肯定，能够进一步降低患者血清 MMP -9、TNF - a 及 LPA 水平，提高临床效果。

【总页数】4页(P379-381,382)
【作者】高萍;孟亚楠;苏立凯
【作者单位】河北大学临床医学院;河北大学临床医学院;河北大学附属医院神经内
科河北保定 071000
【正文语种】中文
【相关文献】
1.都梁软胶囊联合常规西药治疗对偏头痛患者血清5-HT、MMP-9、LPA表达的
影响 [J], 孙亚男; 孙红霞
2.头痛宁胶囊联合氟桂利嗪对偏头痛患者血管内皮功能及应激反应的影响 [J], 张
振刚;张玉蛟;郝春霞;刘新胜
3.普瑞巴林联合盐酸氟桂利嗪对老年偏头痛患者的疗效及血清MMP-9、TNF-α、LPA水平的影响 [J], 王岳宸
4.探讨血瘀型偏头痛患者治疗中采用救脑汤联合常规西药的临床疗效和对血清LPA、TNF-α水平的影响 [J], 刘守国
5.加味散联合盐酸氟桂利嗪治疗偏头痛的疗效及对患者血清5-HT、MMP-9和LPA水平的影响 [J], 韩飞;孙超;刘哲;李志强
因版权原因，仅展示原文概要，查看原文内容请购买。